siRNA, Anti-Human ACTA2, LNA(CAT#: SIRGT04042WQ-LNA)

The product SIRGT04042WQ-LNA is a type of small interfering RNA (siRNA) that targets ACTA2 gene and regulates the expression of gene. The siRNA interferes with the expression of ACTA2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001141945.2; NM_001320855.1; NM_001613.3
Alternative Names ACTSA
Related Diseases Thoracic aortic disease, Coronary artery disease, Stroke, Moyamoya disease
Purification HPLC
Target Gene
Gene ID 59
Uniprot ID P62736

Related Products